Globus Medical (GMED) Earnings Announcement
Medical device company Globus Medical (NYSE:GMED) is set to report its earnings results this Tuesday after the market closes. Here’s an overview of what investors can anticipate.
Last quarter, Globus Medical exceeded analysts’ revenue expectations, posting revenues of $769 million, a remarkable increase of 22.9% year over year. The quarter proved to be exceptional as the company not only beat earnings per share (EPS) estimates but also provided encouraging full-year EPS guidance that surpassed analyst forecasts.
Analysts' Expectations
This quarter, analysts expect Globus Medical’s revenue to grow by 21.8% year over year, a notable improvement from the 6.6% increase reported in the same quarter last year. Over the past 30 days, analysts have reaffirmed their estimates, indicating confidence in the company’s performance as it approaches earnings.
Globus Medical has a strong track record of meeting Wall Street’s revenue expectations. Observing the performance of its peers in the medical devices and supplies specialty segment, we can gain insights into the forthcoming results. For instance, Haemonetics reported a 2.7% decline in revenues year over year but still managed to beat estimates by 2.4%. In contrast, Bausch + Lomb recorded a revenue increase of 9.8%, exceeding expectations by 1.5%. Following the results, Haemonetics saw its stock drop by 10%, while Bausch + Lomb’s price remained stable.
Market Sentiment
The market’s reaction to recent political events, including Trump’s November victory, has been volatile, with potential tariffs affecting investor sentiment. Despite some medical device stocks performing well, the sector has generally underperformed, with an average decline of 3.4% in share prices over the past month. Globus Medical's stock has decreased by 2.6% during the same period, with an average analyst price target set at $107.17, compared to its current share price of $90.06.
At Inside Ticker, we recognize the value of thematic investing. Companies like Microsoft (MSFT), Alphabet (GOOG), Coca-Cola (KO), and Monster Beverage (MNST) have all been identified as growth stories driven by megatrends. In this context, we have pinpointed a lesser-known growth stock benefiting from the rise of AI, available to our members for free via this link.